Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Sep 9, 2022
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$13K
Net Open-Market Flow
$5K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2022Buy(P)307$3.32$1K12K
Aug 29, 2022Buy(P)3K$3.21$9K164K
Aug 26, 2022Sell(S)4K$3.39$13K158K
Aug 26, 2022Buy(P)3K$3.35$9K161K

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-017246) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML